Scalable ACWI 2× vs Amundi MSCI World 2×: What Actually Changed?
Europe now has two young daily leveraged world-equity ETFs, but “world” means something different in each. Scalable's new fund adds emerging markets and lowers the headline fee. The more important differences sit in the benchmark, financing, and a prospectus clause that makes “2×” less absolute than the name suggests.
One correction to the early coverage: this product is no longer merely planned. The fund was launched on July 28, 2026, and Scalable announced it on August 6, 2026.
Scalable versus Amundi at a glance
| Feature | Scalable MSCI AC World X2 | Amundi MSCI World (2x) |
|---|---|---|
| Equity universe | MSCI ACWI: developed and emerging markets | MSCI World: developed markets only |
| Current constituents | About 2,460 across 47 countries | About 1,280 developed-market stocks |
| Ongoing fund cost | 0.45% per year | 0.60% per year |
| Leverage objective | Usually 2× daily; prospectus permits a 1.5×–2× target | 2× daily |
| Benchmark financing | EUR overnight financing (€STR) | USD-denominated strategy index |
| Replication and income | Synthetic swaps; accumulating | Synthetic swaps; accumulating |
| Live history | Fund inception July 28, 2026 | First NAV September 30, 2025 |
The identifiers are LU3386643970 / DBX2SC for Scalable and FR0014010HV4 / ETF888 for Amundi. Both are accumulating UCITS funds using synthetic replication. Neither has enough live history for a convincing long-term product comparison.
What the new “All World” exposure changes
Scalable's benchmark starts with the MSCI ACWI rather than the MSCI World. That adds large- and mid-cap companies from emerging markets to the developed-market universe. At launch, Scalable described roughly 2,460 constituents across 47 countries and about 85% of the global investable equity market.
That is meaningfully broader than MSCI World, but it is not literally every listed company. Small caps remain outside the benchmark. The US will also continue to dominate because ACWI weights companies by free-float market capitalization; adding emerging markets does not create an equal regional allocation.
For an investor choosing between these funds, this benchmark decision is more fundamental than the 0.15 percentage point fee gap. One product is leveraged developed markets; the other is leveraged developed plus emerging markets.
The 0.45% TER is attractive—but not the whole cost
Scalable's annual ongoing charge is 0.45%, compared with Amundi's 0.60%. Scalable calls its product the lowest-cost global equity ETF with 2× leverage in Europe. That is the issuer's comparison, not a guarantee of better investor returns.
A daily leveraged index also pays for the borrowed exposure. Scalable's benchmark subtracts euro overnight financing based on €STR. Fund performance can then differ through swap pricing, tracking, portfolio implementation, taxes inside the benchmark, and trading spreads. Those effects can easily matter more than 0.15% in a volatile year.
Amundi's strategy index is denominated in US dollars, while its shares can trade in euros. Trading currency does not remove currency exposure. Comparing the two products therefore requires more than multiplying the same equity return by two and subtracting each TER.
The name says 2×; the prospectus allows 1.5×–2×
The benchmark targets 2× daily exposure. The fund documents add an important second layer: DWS says the fund will usually target 200%, but may target between 150% and 200%. Scalable, acting as portfolio-construction adviser, can recommend a lower target after considering factors such as demand, swap terms, counterparties, and financing. DWS decides whether to implement that recommendation.
If the target is reduced, the remainder can sit in liquid or short-duration assets. Investors are meant to be notified through the Xtrackers website. This does not make the “2×” label meaningless, but it does mean a historical backtest with a permanent 2× target cannot promise to reproduce the fund's future path.
Daily leverage remains a one-day objective
The KID uses a one-day recommended holding period and a summary risk indicator of 5 out of 7. The daily objective matters: over weeks or years, the result depends on the order of returns, not just the benchmark's start and end points. Choppy markets can create volatility drag; persistent trends can create favorable compounding.
- A sharp market fall is magnified, and the documents warn that total capital loss is possible.
- Synthetic replication adds swap-counterparty and collateral risks.
- Emerging markets broaden diversification while adding political, liquidity, and currency risks.
- Tracking can diverge from both the unleveraged market and the published leveraged benchmark.
- The product is extremely new, so hypothetical history should not be confused with a fund track record.
Our guides to volatility decay and leverage expansion show both sides of daily compounding.
An honest simulation needs an honest label
Official historical MSCI ACWI Leveraged 2X Select data is not part of this site. Instead, our backtester uses the adjusted-close history of the EUR-traded iShares MSCI ACWI UCITS ETF (IUSQ) as a market proxy. It applies a generic daily-reset leverage formula, historical EONIA/€STR financing, and the selected management fee.
We deliberately leave IUSQ's own 0.20% fee and tracking difference embedded in the source series rather than “correcting” them with another assumption. That introduces a conservative drag. The model also omits the Select benchmark's staggered-reset adjustment, actual swap pricing and tracking, and any future change in the fund's leverage target. The result is a research aid—not reconstructed DBX2SC performance.
Run the two benchmarks separately. Their results are not an apples-to-apples fund comparison because the underlying universes, currencies, data proxies, and financing assumptions differ.
Bottom line
Scalable's ETF is a genuine expansion of Europe's leveraged-equity menu: emerging markets, a lower TER, and euro-based financing in one UCITS fund. It is not simply a cheaper copy of Amundi's product, and the legal ability to vary the target leverage deserves more attention than it will probably receive in a fee comparison.
Leveraged ETFs are complex and can lose money rapidly. This article and simulator are educational, not financial advice.